Mehmet Asim Bilen
Mehmet Asim Bilen
Winship Cancer Institute of Emory University
Dirección de correo verificada de - Página principal
Citado por
Citado por
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
NM Kuderer, TK Choueiri, DP Shah, Y Shyr, SM Rubinstein, DR Rivera, ...
The Lancet 395 (10241), 1907-1918, 2020
An intra-tumoral niche maintains and differentiates stem-like CD8 T cells
CS Jansen, N Prokhnevska, VA Master, MG Sanda, JW Carlisle, MA Bilen, ...
Nature 576 (7787), 465-470, 2019
Frailty and cancer: implications for oncology surgery, medical oncology, and radiation oncology
CG Ethun, MA Bilen, AB Jani, SK Maithel, K Ogan, VA Master
CA: a cancer journal for clinicians 67 (5), 362-377, 2017
Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium
P Grivas, AR Khaki, TM Wise-Draper, B French, C Hennessy, CY Hsu, ...
Annals of oncology 32 (6), 787-800, 2021
Association of convalescent plasma therapy with survival in patients with hematologic cancers and COVID-19
MA Thompson, JP Henderson, PK Shah, SM Rubinstein, MJ Joyner, ...
JAMA oncology 7 (8), 1167-1175, 2021
Incidence of immune-related adverse events and its association with treatment outcomes: the MD Anderson Cancer Center experience
T Fujii, RR Colen, MA Bilen, KR Hess, J Hajjar, ME Suarez-Almazor, ...
Investigational new drugs 36, 638-646, 2018
Cabozantinib in advanced non-clear-cell renal cell carcinoma: a multicentre, retrospective, cohort study
NM Chanzá, W Xie, MA Bilen, H Dzimitrowicz, J Burkart, DM Geynisman, ...
The lancet oncology 20 (4), 581-590, 2019
Cadherin-11 increases migration and invasion of prostate cancer cells and enhances their interaction with osteoblasts
CF Huang, C Lira, K Chu, MA Bilen, YC Lee, X Ye, SM Kim, A Ortiz, ...
Cancer research 70 (11), 4580-4589, 2010
Enfortumab vedotin plus pembrolizumab in previously untreated advanced urothelial cancer
CJ Hoimes, TW Flaig, MI Milowsky, TW Friedlander, MA Bilen, S Gupta, ...
Journal of clinical oncology 41 (1), 22-31, 2023
BMP4 promotes prostate tumor growth in bone through osteogenesis
YC Lee, CJ Cheng, MA Bilen, JF Lu, RL Satcher, LY Yu-Lee, GE Gallick, ...
Cancer research 71 (15), 5194-5203, 2011
Lenvatinib plus pembrolizumab in patients with either treatment-naive or previously treated metastatic renal cell carcinoma (Study 111/KEYNOTE-146): a phase 1b/2 study
CH Lee, AY Shah, D Rasco, A Rao, MH Taylor, C Di Simone, JJ Hsieh, ...
The lancet oncology 22 (7), 946-958, 2021
18F-fluciclovine-PET/CT imaging versus conventional imaging alone to guide postprostatectomy salvage radiotherapy for prostate cancer (EMPIRE-1): a single centre, open-label …
AB Jani, E Schreibmann, S Goyal, R Halkar, B Hershatter, PJ Rossi, ...
The Lancet 397 (10288), 1895-1904, 2021
The prognostic and predictive impact of inflammatory biomarkers in patients who have advanced‐stage cancer treated with immunotherapy
MA Bilen, DJ Martini, Y Liu, C Lewis, HH Collins, JM Shabto, M Akce, ...
Cancer 125 (1), 127-134, 2019
CD8+ T cell activation in cancer comprises an initial activation phase in lymph nodes followed by effector differentiation within the tumor
N Prokhnevska, MA Cardenas, RM Valanparambil, E Sobierajska, ...
Immunity 56 (1), 107-124. e5, 2023
Study EV-103: preliminary durability results of enfortumab vedotin plus pembrolizumab for locally advanced or metastatic urothelial carcinoma.
JE Rosenberg, TW Flaig, TW Friedlander, MI Milowsky, S Srinivas, ...
Journal of Clinical Oncology 38 (6_suppl), 441-441, 2020
Acute rhabdomyolysis with severe polymyositis following ipilimumab-nivolumab treatment in a cancer patient with elevated anti-striated muscle antibody
MA Bilen, SK Subudhi, J Gao, NM Tannir, SM Tu, P Sharma
Journal for immunotherapy of cancer 4, 1-5, 2016
Sites of metastasis and association with clinical outcome in advanced stage cancer patients treated with immunotherapy
MA Bilen, JM Shabto, DJ Martini, Y Liu, C Lewis, H Collins, M Akce, ...
BMC cancer 19, 1-8, 2019
Radiomics to predict immunotherapy-induced pneumonitis: proof of concept
RR Colen, T Fujii, MA Bilen, A Kotrotsou, S Abrol, KR Hess, J Hajjar, ...
Investigational new drugs 36, 601-607, 2018
Characterization of metastatic urothelial carcinoma via comprehensive genomic profiling of circulating tumor DNA
N Agarwal, SK Pal, AW Hahn, RH Nussenzveig, GR Pond, SV Gupta, ...
Cancer 124 (10), 2115-2124, 2018
Ductal adenocarcinoma of the prostate: clinical features and implications after local therapy
SM Tu, A Lopez, D Leibovici, MA Bilen, F Evliyaoglu, A Aparicio, CC Guo, ...
Cancer 115 (13), 2872-2880, 2009
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20